Need Tally
for Clients?

Contact Us! Here

  Tally Auditor

License (Renewal)
  Tally Gold

License Renewal

  Tally Silver

License Renewal
  Tally Silver

New Licence
  Tally Gold

New Licence
 
Open DEMAT Account with in 24 Hrs and start investing now!
« Top Headlines »
Open DEMAT Account in 24 hrs
 March 31 deadline is getting near. How to save income tax with tax loss harvesting?
 45-day MSME payment rule: Impact and details of Section 43B(h) explained
 Small savings schemes that offer tax benefits of up to Rs 1.5 lakh under section 80C
 RE-OPENING OF CORRECTION WINDOW FOR MAY 2024 CA EXAMINATIONS
 Powerful Upgrades, Tally 12+1 months renewal Plan and Connected Services for your growing Business - March 2024
 How innovative solutions can help fix the Sec 43B conundrum for MSMEs
 Income Tax dept asks many individuals to explain high value transactions of FY20-21 as Updated ITR deadline nears
 Release Notes for TallyPrime and TallyPrime Edit Log Release 4.1 | What s New!
 Deadline to file updated ITR FY20-21 ends on March 31: Details on additional tax
 4 tax-planning mistakes to avoid this season
 ITR 2024: Here are 8 ways by which senior citizens can save on taxes this year

Cabinet to look into amendment
November, 21st 2006
In a move that will boost the pharmaceutical sector, the Cabinet Committee on World Trade Organisation is expected to take up a proposal for amending the compulsory license clause in the Trade-Related Intellectual Property Rights (TRIPS) agreement. 
 
Once this decision is taken, the Centre will propose to WTO to waive off the obligation under Article 31(f) and Article 31(h) of the TRIPS agreement, so that it can directly export pharma products to countries having insufficient or no manufacturing capacity. 
 
Under the current circumstances, a government has an exceptional provision of allowing a pharma company to produce the patented product or process without the consent of the patent owner in case of a medical emergency. 
 
But if the article is relaxed for India, domestic companies will be able to export the products to other countries in case of national emergencies without the authorisation of the patent holder. 
 
Article 31(h) of TRIPS specifies that the right holder shall be paid adequate remuneration in the circumstances of each case, taking into account the economic value of the authorisation benefit.
Home | About Us | Terms and Conditions | Contact Us
Copyright 2024 CAinINDIA All Right Reserved.
Designed and Developed by Ritz Consulting